GSK’s Promacta Effective In Raising Platelet Count In HCV-Associated Thrombocytopenia, Phase II Data Show
This article was originally published in The Pink Sheet Daily
Executive Summary
Results published in the New England Journal of Medicine demonstrate 95 percent of hepatitis C patients with thrombocytopenia taking 75 mg dose of eltrombopag once daily had elevated platelet counts.